Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Klatskin Tumor 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 197Bevacizumab 161Fluorouracil 154Capecitabine 137Gemcitabine 134Leucovorin 111pembrolizumab 99Cisplatin 94Drug Therapy 89Irinotecan 80Radiotherapy 73sintilimab 70130-nm albumin-bound paclitaxel 66durvalumab 65Paclitaxel 64Specimen Handling 62Cetuximab 61lenvatinib 59tislelizumab 58Nivolumab 55Magnetic Resonance Spectroscopy 55Folfox protocol 55Blood Specimen Collection 52atezolizumab 47Biopsy 46Surgical Procedures, Operative 40Taxes 39Albumin-Bound Paclitaxel 39Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Pancreatic Hormones × Gastrointestinal × Clear all
NCT05128890 2026-03-20

Evaluation of Resection Techniques for Pancreatic Tumors

Methodist Health System

Recruiting
431 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Pancreatic Neoplasms

NCT06850753 2025-08-21

SURE-LT

Oslo University Hospital

Phase NA Recruiting
15 enrolled
Gastrointestinal

Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡